Product Wiki · Recalls · EU Safety Gate (RAPEX)

UV & LED Gel Colorful Collection — recall SR/04328/25

EU Safety Gate (RAPEX) · Germany · 2025-12-12 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/04328/25
Date of alert
2025-12-12
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
NailsUp
Product category
Cosmetics
Product type
Nail gel
Barcode (EAN/GTIN)
5949243131575
🔴 Serious hazard — Reported risk: The product contains dyes CI 45170, Cl 45160 and Basic Yellow 40, p-hydroxyanisole, trimethylbenzoyl diphenylphosphine oxide (TPO) and 2-hydroxyethyl methacrylate (HEMA).which are banned in cosmetic products. All these can cause serious eye or skin irritation Azodyes may cause cancer, cell mutations and affect reproduction. HEMA may also cause allergic skin reaction. TPO may also harm the reproductive system and the health of the unborn child.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
20/10/2025
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10096961

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.